Join us for an evening dedicated to networking and investment opportunities with top Italian pharma and biotech companies and discover why Italy is one of the world's greatest centers
Location: Italian Innovation Centre - INNOVIT, San Francisco at 710 Sansome Street, CA.
Signs of intra-tumor pro-inflammatory state in patients; Temferon™ induced immune system reset in preclinical studies; Macrophage and T cell profiles in patients’ tumor microenvironment echo preclinical findings
• Current dose escalation study data shows a median overall survival of 17 months
• Adding cohort to Phase 1/2a trial in GBM to assess additional conditioning regimen
• Cash and cash equivalents of €34.7 million as of June 30, 2022, providing a cash runway until the end of 2024
• €1.8 million unrealized foreign exchange gain